These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 1562353)

  • 1. Hepatic release of carnitine: effect of increased concentration by clofibrate treatment.
    Paul HS; Sekas G
    Biochem Med Metab Biol; 1992 Feb; 47(1):21-30. PubMed ID: 1562353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of increased hepatic concentration of carnitine by clofibrate.
    Paul HS; Gleditsch CE; Adibi SA
    Am J Physiol; 1986 Sep; 251(3 Pt 1):E311-5. PubMed ID: 3092678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment with pharmacological peroxisome proliferator-activated receptor alpha agonist clofibrate causes upregulation of organic cation transporter 2 in liver and small intestine of rats.
    Ringseis R; Pösel S; Hirche F; Eder K
    Pharmacol Res; 2007 Aug; 56(2):175-83. PubMed ID: 17644405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of carnitine and propionate with pyruvate oxidation by hepatocytes from clofibrate-treated rats: importance of coenzyme A availability.
    Brass EP
    J Nutr; 1992 Feb; 122(2):234-40. PubMed ID: 1732464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of ciprofibrate and 2-[5-(4-chlorophenyl)pentyl]oxirane-2-carboxylate (POCA) on the distribution of carnitine and CoA and their acyl-esters and on enzyme activities in rats. Relation between hepatic carnitine concentration and carnitine acetyltransferase activity.
    Bhuiyan AK; Bartlett K; Sherratt HS; Agius L
    Biochem J; 1988 Jul; 253(2):337-43. PubMed ID: 3178716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clofibrate enhancement of mitochondrial carnitine transport system of rat liver and augmentation of liver carnitine and gamma-butyrobetaine hydroxylase activity by thyroxine.
    Pande SV; Parvin R
    Biochim Biophys Acta; 1980 Mar; 617(3):363-70. PubMed ID: 7370283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paradoxical effects of clofibrate on liver and muscle metabolism in rats. Induction of myotonia and alteration of fatty acid and glucose oxidation.
    Paul HS; Adibi SA
    J Clin Invest; 1979 Aug; 64(2):405-12. PubMed ID: 457859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Release of carnitine from the perfused rat liver.
    Sandor A; Kispal G; Melegh B; Alkonyi I
    Biochim Biophys Acta; 1985 Jun; 835(1):83-91. PubMed ID: 4005277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clofibrate-induced increase in carnitine and acylcarnitine content in rats.
    Kähönen MT
    Biochem Pharmacol; 1979 Dec; 28(24):3674-7. PubMed ID: 533567
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of clofibrate on the metabolism of oleate in the perfused rat liver.
    Ide T; Sugano M
    Biochem Pharmacol; 1983 Sep; 32(17):2583-8. PubMed ID: 6615553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment with pharmacological peroxisome proliferator-activated receptor alpha agonist clofibrate increases intestinal carnitine absorption in rats.
    Ringseis R; Lüdi S; Hirche F; Eder K
    Pharmacol Res; 2008 Jul; 58(1):58-64. PubMed ID: 18620058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic fatty acid oxidation and ketogenesis after clofibrate treatment.
    Mannaerts GP; Thomas J; Debeer LJ; McGarry JD; Foster DW
    Biochim Biophys Acta; 1978 May; 529(2):201-11. PubMed ID: 656451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fuel homeostasis and carnitine metabolism in rats with secondary biliary cirrhosis.
    Krahenbuhl S; Brass EP
    Hepatology; 1991 Nov; 14(5):927-34. PubMed ID: 1937397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of clofibrate, cholestyramine, zanchol, probucol, and AOMA feeding on hepatic and intestinal cholesterol metabolism and on biliary lipid secretion in the rat.
    Turley SD; Dietschy JM
    J Cardiovasc Pharmacol; 1980; 2(3):281-97. PubMed ID: 6156326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of clofibrate and acetylsalicylic acid on hepatic carnitine palmitoyltransferase synthesis.
    Brady PS; Brady LJ
    Biochem Pharmacol; 1989 Mar; 38(5):811-4. PubMed ID: 2930581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reciprocal responses to clofibrate in ketogenesis and triglyceride and cholesterol secretion in isolated rat liver.
    Ide T; Oku H; Sugano M
    Metabolism; 1982 Oct; 31(10):1065-72. PubMed ID: 7132732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased pivaloylcarnitine in the liver of the sodium pivalate treated rat exposed to clofibrate.
    Diep QN; Bøhmer T
    Biochim Biophys Acta; 1995 May; 1256(2):245-7. PubMed ID: 7766704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of carnitine acyltransferase synthesis in lean and obese Zucker rats by dehydroepiandrosterone and clofibrate.
    Brady LJ; Ramsay RR; Brady PS
    J Nutr; 1991 Apr; 121(4):525-31. PubMed ID: 1826132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of clofibrate and gemfibrozil on the activities of mitochondrial carnitine acyltransferases in rat liver. Dose--response relations.
    Kähönen MT; Ylikahri RH
    Atherosclerosis; 1979 Jan; 32(1):47-56. PubMed ID: 465113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acinar heterogeneity of fatty acid binding protein expression in the livers of male, female and clofibrate-treated rats.
    Bass NM; Barker ME; Manning JA; Jones AL; Ockner RK
    Hepatology; 1989 Jan; 9(1):12-21. PubMed ID: 2642289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.